BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 9525971)

  • 21. Regulation of the sodium/iodide symporter by retinoids--a review.
    Schmutzler C
    Exp Clin Endocrinol Diabetes; 2001; 109(1):41-4. PubMed ID: 11573138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
    Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
    World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
    Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.
    Choi HJ; Kim TY; Ruiz-Llorente S; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
    Nucl Med Biol; 2012 Nov; 39(8):1275-80. PubMed ID: 22995901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The miR-146b-3p/PAX8/NIS Regulatory Circuit Modulates the Differentiation Phenotype and Function of Thyroid Cells during Carcinogenesis.
    Riesco-Eizaguirre G; Wert-Lamas L; Perales-Patón J; Sastre-Perona A; Fernández LP; Santisteban P
    Cancer Res; 2015 Oct; 75(19):4119-30. PubMed ID: 26282166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium/iodide symporter mRNA expression in cold thyroid nodules.
    Paschke R; Neumann S
    Exp Clin Endocrinol Diabetes; 2001; 109(1):45-6. PubMed ID: 11573139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.
    Saito T; Endo T; Kawaguchi A; Ikeda M; Nakazato M; Kogai T; Onaya T
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3331-6. PubMed ID: 9329364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME
    J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter.
    Ryu KY; Senokozlieff ME; Smanik PA; Wong MG; Siperstein AE; Duh QY; Clark OH; Mazzaferri EL; Jhiang SM
    Thyroid; 1999 Apr; 9(4):405-9. PubMed ID: 10319949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas.
    Arturi F; Russo D; Giuffrida D; Schlumberger M; Filetti S
    Eur J Endocrinol; 2000 Nov; 143(5):623-7. PubMed ID: 11078986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium iodide symporter and pendrin expression in human thyroid tissues.
    Mian C; Lacroix L; Alzieu L; Nocera M; Talbot M; Bidart JM; Schlumberger M; Caillou B
    Thyroid; 2001 Sep; 11(9):825-30. PubMed ID: 11575851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas.
    Gérard AC; Daumerie C; Mestdagh C; Gohy S; De Burbure C; Costagliola S; Miot F; Nollevaux MC; Denef JF; Rahier J; Franc B; De Vijlder JJ; Colin IM; Many MC
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4977-83. PubMed ID: 14557483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid.
    Wapnir IL; Goris M; Yudd A; Dohan O; Adelman D; Nowels K; Carrasco N
    Clin Cancer Res; 2004 Jul; 10(13):4294-302. PubMed ID: 15240514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
    Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta1 suppresses thyrotropin-induced Na+/I- symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells.
    Kawaguchi A; Ikeda M; Endo T; Kogai T; Miyazaki A; Onaya T
    Thyroid; 1997 Oct; 7(5):789-94. PubMed ID: 9349586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of sodium-iodide symporter and TSH receptor in subclinical metastatic lymph nodes of papillary thyroid microcarcinoma.
    So YK; Son YI; Baek CH; Jeong HS; Chung MK; Ko YH
    Ann Surg Oncol; 2012 Mar; 19(3):990-5. PubMed ID: 21879263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
    Venkataraman GM; Yatin M; Marcinek R; Ain KB
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
    Joba W; Spitzweg C; Schriever K; Heufelder AE
    Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid communication: predominant intracellular overexpression of the Na(+)/I(-) symporter (NIS) in a large sampling of thyroid cancer cases.
    Dohán O; Baloch Z; Bánrévi Z; Livolsi V; Carrasco N
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2697-700. PubMed ID: 11397873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.